ALLERGY AND ASTHMA PROCEEDINGS
Scope & Guideline
Bridging science and practice in respiratory medicine.
Introduction
Aims and Scopes
- Clinical Research in Allergic Diseases:
The journal publishes studies that investigate various allergic conditions, including food allergies, allergic rhinitis, and atopic dermatitis, emphasizing clinical outcomes, diagnostic approaches, and treatment efficacy. - Translational Research:
Research that bridges laboratory findings to clinical applications is a priority. This includes studies on biomarkers, immunotherapy, and novel therapeutic agents for managing allergic diseases and asthma. - Real-World Data and Effectiveness Studies:
The journal emphasizes the importance of real-world effectiveness studies that assess treatment outcomes in diverse populations, providing insights into the practical implications of therapeutic strategies. - Longitudinal and Cohort Studies:
Long-term studies that track disease progression, treatment responses, and patient quality of life are highlighted, contributing to a deeper understanding of chronic allergic conditions. - Diversity of Patient Populations:
Research focusing on underrepresented groups and health disparities in allergic disease management is an essential aspect, aiming to improve care across different demographics.
Trending and Emerging
- Biologics and Targeted Therapies:
There is a significant increase in research focused on biologics and targeted therapies, particularly in managing severe asthma and chronic allergic conditions, highlighting their efficacy and safety in real-world settings. - Patient-Centered Outcomes and Quality of Life:
Emerging themes emphasize the importance of patient-reported outcomes and quality of life assessments, reflecting a growing recognition of the holistic aspects of managing allergic diseases. - Impact of COVID-19 on Allergy Management:
The pandemic has spurred a surge in research examining the implications of COVID-19 on allergy management, including vaccine responses and the management of allergic conditions during public health crises. - Health Disparities and Access to Care:
Emerging studies are increasingly addressing health disparities in allergic disease management, with a focus on improving access to care and understanding the socio-economic factors influencing treatment outcomes. - Gut Microbiome and Allergic Disease:
Research exploring the relationship between the gut microbiome and allergic diseases is on the rise, indicating a growing interest in how microbial exposure influences immune responses and allergy development.
Declining or Waning
- Traditional Allergy Testing Methods:
There has been a noticeable decline in studies focused on traditional allergy testing methods such as skin prick tests and intradermal testing, as newer, more precise diagnostic techniques gain traction. - Generalized Asthma Management Strategies:
Research addressing broad asthma management strategies without specific focus on personalized approaches or biomarker utilization seems to be waning, as the field shifts toward more tailored treatments. - Basic Immunology Studies:
While foundational immunological research remains important, there appears to be a reduced emphasis on basic science studies that do not directly translate into clinical applications or patient care advancements. - Single-Agent Therapy Studies:
The focus on studies evaluating single-agent therapies for allergic conditions is declining, with a shift towards combination therapies and multi-modal treatment approaches being preferred in recent literature.
Similar Journals
Egyptian Journal of Pediatric Allergy and Immunology
Exploring breakthroughs in allergy and immunology for children.Welcome to the Egyptian Journal of Pediatric Allergy and Immunology, a leading academic platform dedicated to the advancement of knowledge in the field of pediatric allergy and immunology. Published by the prestigious Egyptian Society of Pediatric Allergy & Immunology, this journal aims to address the pressing challenges and breakthroughs in the diagnosis, treatment, and management of allergic diseases in children. As a crucial resource for researchers, healthcare professionals, and students, it focuses on disseminating high-quality, peer-reviewed articles that contribute to the global understanding of allergic conditions and immunological responses in pediatric populations. Although the journal is currently not an Open Access publication, it provides a valuable gateway to research findings that can shape clinical practice and influence future investigations. With an emphasis on contributing to improved healthcare outcomes for children suffering from allergy and immunology disorders, the Egyptian Journal of Pediatric Allergy and Immunology stands out as an essential reference in the field.
Allergy Asthma & Respiratory Disease
Bridging science and practice in respiratory medicine.Allergy Asthma & Respiratory Disease is a pioneering journal dedicated to advancing research and clinical practice in the fields of allergy, asthma, and related respiratory diseases. Published by the esteemed Korean Academy of Asthma Allergy & Clinical Immunology, this journal aims to disseminate high-quality, peer-reviewed articles that contribute to the understanding, diagnosis, and treatment of these prevalent health issues. Although it operates under a subscription model, it maintains a robust reputation for being a pivotal resource in respiratory health, attracting authors and researchers worldwide. The journal emphasizes interdisciplinary approaches and encourages submissions that span from molecular biology to public health perspectives, making it a vital platform for professionals, researchers, and students eager to deepen their knowledge in respiratory medicine. With a commitment to fostering academic discourse in South Korea and beyond, Allergy Asthma & Respiratory Disease is positioned as a significant contributor to the global conversation on respiratory health.
Current Opinion in Allergy and Clinical Immunology
Empowering professionals with cutting-edge reviews and opinions.Current Opinion in Allergy and Clinical Immunology, published by Lippincott Williams & Wilkins, is a pivotal journal that serves as a key resource for professionals in the fields of immunology and allergy. With an ISSN of 1528-4050 and an E-ISSN of 1473-6322, this journal presents cutting-edge reviews of the latest research findings, methodologies, and therapeutic approaches in the management of allergic and immunological disorders. With a Q3 category ranking in both Immunology and Allergy for 2023, and a Scopus rank of #103 in Immunology and Allergy, it reflects a solid position within the scientific community. Operating in the highly dynamic fields of immunology and clinical practice since its inception in 2001, the journal aims to harmonize emerging research trends with clinical applications to enhance patient outcomes. Although it does not currently offer Open Access options, the journal's substantial impact factor attests to its significance as a scholarly resource. By disseminating high-quality reviews and expert opinions, Current Opinion in Allergy and Clinical Immunology continues to foster knowledge advancement and professional development among researchers, practitioners, and students alike.
RMD Open
Connecting global minds in Immunology and Allergy.RMD Open, published by the BMJ Publishing Group, is a leading open-access journal that has made significant contributions to the fields of Immunology, Immunology and Allergy, and Rheumatology since its inception in 2015. With an impressive Q1 ranking in these categories for 2023, the journal has established itself as an essential platform for the dissemination of high-quality research, case studies, and reviews that advance understanding and treatment strategies in these critical areas of health. As an open-access publication, RMD Open ensures that its content is freely accessible to a global audience, promoting collaboration and knowledge sharing among researchers, clinicians, and students. Based in the United Kingdom at the British Medical Association House, RMD Open is not only dedicated to improving patient care but also to fostering innovative research and discussions in the rapidly evolving landscape of rheumatic diseases.
Allergo Journal
Unveiling the complexities of immune disorders.Welcome to the Allergo Journal, a pivotal publication in the field of Immunology and Allergy, housed under the esteemed SPRINGER HEIDELBERG publishing house. With an ISSN of 0941-8849 and E-ISSN 2195-6405, the journal has been serving the scientific community since its inception in 1994. Although its Scopus coverage was discontinued in 2017, the journal remains significant, ranked #135 out of 186 in its category and positioned in the 27th percentile, reflecting its contributions to vital research in allergy and immunological disorders. While the journal is not an open access publication, it continues to provide a platform for rigorous academic discourse and advances in the study of allergens and immune response. The Allergo Journal stands as a crucial resource for researchers, professionals, and students dedicated to deepening their understanding of allergies and immunology, fostering advancements in therapy and comprehensive patient care.
CURRENT ALLERGY AND ASTHMA REPORTS
Shaping the Future of Allergy and Asthma ManagementCURRENT ALLERGY AND ASTHMA REPORTS, published by CURRENT MEDICINE GROUP, is a premier journal dedicated to advancing knowledge in the fields of allergy, asthma, and pulmonary medicine. With an impressive impact factor and a distinguished position in the Scopus ranking system—holding the 12th spot in Pulmonary and Respiratory Medicine and 40th in Immunology and Allergy—this journal is vital for researchers, clinicians, and healthcare professionals aiming to stay abreast of the latest developments and evidence-based practices. Since its inception in 2001, the journal has committed to publishing rigorous research articles, reviews, and expert opinion pieces that inform both clinical practice and research initiatives. Although it does not currently offer open access, it continues to maintain a robust platform for disseminating critical findings and fostering scholarly dialogue, ensuring it remains an essential resource for those dedicated to improving patient outcomes in respiratory health.
Current Allergy & Clinical Immunology
Navigating the complexities of allergy and immunity.Current Allergy & Clinical Immunology is a vital peer-reviewed journal published by the Allergy Society of South Africa, focused on advancing the field of immunology and allergy medicine. With an ISSN of 1609-3607, this journal offers crucial insights and research findings pertinent to the understanding and treatment of allergic conditions. Operating from South Africa, it features contributions from a diverse range of authors and professionals in the field. Published from 2008 to 2024, the journal plays an essential role in disseminating current knowledge, even as it holds a Q4 ranking in Immunology and Allergy and is positioned at the 4th percentile based on Scopus rankings. While not open access, it remains an important resource for researchers, practitioners, and students looking to stay informed on emerging trends and breakthroughs in allergy and clinical immunology.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
Pioneering Research for a Breath of Fresh AirANNALS OF ALLERGY ASTHMA & IMMUNOLOGY is a premier peer-reviewed journal published by Elsevier Science Inc, dedicated to advancing the fields of allergy, asthma, and immunology. With its roots dating back to 1995 and with a focus on high-impact research, this journal has established itself as a leading platform for the dissemination of original research, reviews, and clinical studies within these critical areas. The journal boasts an impressive impact factor, supporting its Q2 ranking in both Immunology and Allergy, as well as in Pulmonary and Respiratory Medicine, indicating its significant contribution to the scientific community. Although it does not currently offer open access options, its comprehensive coverage and rigorous peer-review process ensure that published articles are of the highest quality, making it an invaluable resource for researchers, clinicians, and students alike. The Scopus rankings reflect its esteemed position in the academic landscape, providing professionals with access to cutting-edge developments and insights into the management and treatment of allergic and respiratory conditions.
BMC Pulmonary Medicine
Exploring groundbreaking discoveries in respiratory medicine.BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.
CLINICAL AND EXPERIMENTAL ALLERGY
Empowering Knowledge in Allergy and ImmunologyCLINICAL AND EXPERIMENTAL ALLERGY is a premier peer-reviewed journal dedicated to advancing the scientific understanding of allergy and immunology. Published by Wiley in the United Kingdom, this esteemed journal maintains a significant impact factor, reflecting its high standards and influential research contributions. With an impressive history since its inception in 1971, the journal is poised to continue leading the discourse in the field until at least 2024. It is ranked in the Q2 quartile for both Immunology and Allergy categories, further highlighting its reputable standing within the academic community. The journal's Scopus rankings showcase its academic relevance, securing the 49th and 51st positions in the Medicine and Immunology categories, respectively. Researchers, professionals, and students will find vital insights and contemporary research trends within its pages, making it an essential resource for those invested in understanding and addressing allergic diseases and disorders.